Ondansetron Export Market Intelligence: India's 537 Suppliers Shipping to 157 Countries — TransData Nexus 2026

Q: Who are the top ondansetron exporters from India?

The top ondansetron exporters from India are: 1. AUROBINDO PHARMA LTD — $31.2M (25.8% market share); 2. GLENMARK PHARMACEUTICALS LIMITED — $15.9M (13.2% market share); 3. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED — $10.8M (8.9% market share); 4. AUROBINDO PHARMA LIMITED — $9.8M (8.1% market share); 5. GLAND PHARMA LIMITED — $5.9M (4.9% market share). Together they account for 60.9% of India's total ondansetron export value.

Q: What is the total export value of ondansetron from India?

The total export value of ondansetron from India is $121.0M USD, recorded across 8,469 shipment transactions from 537 active exporters to 157 destination countries. The average shipment value is $14.3K.

Q: Which countries import ondansetron from India?

India exports ondansetron to 157 countries worldwide. The top importing countries are: UNITED STATES (58.8% share, $71.2M), AUSTRALIA (6.0% share, $7.3M), SOUTH AFRICA (5.7% share, $7.0M), CANADA (3.1% share, $3.8M), BELGIUM (2.3% share, $2.8M). These five markets account for 76.0% of total export value.

Q: What is the HS code for ondansetron exports from India?

The primary HS code for ondansetron exports from India is 30049035. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ondansetron exports from India?

The average unit price for ondansetron exports from India is $1.72 USD per unit, with prices ranging from $0.00 to $5282.82 depending on formulation, packaging, and order volume. The total market is valued at $121.0M across 8,469 shipments.

Q: Which ports handle ondansetron exports from India?

The primary ports for ondansetron exports from India are SAHAR AIR CARGO ACC (INBOM4) (12.5% of shipments), NHAVA SHEVA SEA (INNSA1) (12.1% of shipments), SAHAR AIR (11.7% of shipments), HYDERABAD ICD (INSNF6) (6.0% of shipments), HYDERABAD ICD (5.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ondansetron?

India is one of the world's leading exporters of ondansetron due to its large base of 537 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ondansetron to 157 countries, demonstrating 81% global market coverage.

Q: What certifications do Indian ondansetron exporters need?

Indian ondansetron exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ondansetron from India?

There are 1,636 registered buyers importing ondansetron from India, spread across 157 countries. The repeat buyer rate is 54.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ondansetron supplier from India?

AUROBINDO PHARMA LTD is the leading ondansetron exporter from India with a market share of 25.8% and total export value of $31.2M across 741 shipments. The top 5 suppliers together control 60.9% of total export value.

Suresh Sormare

Ondansetron

India Pharmaceutical Trade Intelligence

$121.0M537 Suppliers157 CountriesHS 30049035

ExportsIndia → UNITED STATES58.8%India → AUSTRALIA6.0%

ImportsUNITED STATES → India$21.1K UNITED KINGDOM → India$14.4K

#1 Buyer: GLENMARK PHARMACEUTICALS

Ondansetron Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ondansetron to the World

Between 2022 and 2026, India exported $121.0M worth of ondansetron across 8,469 verified shipments to 157 countries — covering 81% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (58.8%). AUROBINDO PHARMA LTD leads with a 25.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ondansetron export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ondansetron export data snapshot — $121.0M · 537 exporters · 157 countriesTransData Nexus · Indian Customs Data

Top Ondansetron Exporters from India

537 active exporters · Ranked by export value

View all 537 →

Top Ondansetron Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AUROBINDO PHARMA LTD	$31.2M	741	14	25.8%
2	GLENMARK PHARMACEUTICALS LIMITED

Top Countries Importing Ondansetron from India

157 destination markets · Ranked by import value

All 157 countries →

Top Countries Importing Ondansetron from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$71.2M	58.8%
2	AUSTRALIA	$7.3M	6.0%
3	SOUTH AFRICA	$7.0M	5.7%
4	CANADA	$3.8M	3.1%
5	BELGIUM	$2.8M	2.3%
6	COLOMBIA	$2.4M	2.0%
7	NEW ZEALAND	$1.9M	1.6%
8	KUWAIT	$1.8M	1.5%
9	BRAZIL	$1.8M	1.5%
10	TURKEY	$1.8M	1.5%

UNITED STATES is India's largest ondansetron export destination, absorbing 58.8% of total exports worth $71.2M. The top 5 importing countries — UNITED STATES, AUSTRALIA, SOUTH AFRICA, CANADA, BELGIUM — together account for 76.0% of India's total ondansetron export value. The remaining 152 destination countries collectively receive the other 24.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ondansetron to India?

11 origin countries · Total import value: $65.7K

India imports ondansetron from 11 countries with a combined import value of $65.7K. The largest supplier is UNITED STATES ($21.1K, 25 shipments), followed by UNITED KINGDOM and IRAQ. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ondansetron to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$21.1K	25	32.1%
2	UNITED KINGDOM	$14.4K	12	22.0%
3	IRAQ	$10.0K	1	15.3%
4	CANADA	$7.0K	21	10.6%
5	GERMANY	$5.2K	8	7.9%
6	BRAZIL	$3.6K	4	5.4%
7	AUSTRALIA	$2.2K	3	3.3%
8	NETHERLANDS	$1.4K	1	2.1%
9	ITALY	$443	2	0.7%
10	GUYANA	$240	1	0.4%

Showing top 10 of 11 origin countries

UNITED STATES is the largest supplier of ondansetron to India, accounting for 32.1% of total import value. The top 5 origin countries — UNITED STATES, UNITED KINGDOM, IRAQ, CANADA, GERMANY — together supply 87.9% of India's ondansetron imports. Click any country to see detailed supplier and buyer data for that import corridor.

Ondansetron — Export Intelligence Video

Visual overview of India's ondansetron import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's ondansetron pharmaceutical import and export market — $121.0M in total trade, 537 verified manufacturers, and 157 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Ondansetron

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Ondansetron, a 5-HT3 receptor antagonist, is widely utilized in the United States to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for ondansetron, indicating a competitive generic market. Notably, the FDA has issued safety communications regarding ondansetron. In September 2011, the agency highlighted potential risks of abnormal heart rhythms associated with the drug's use. Subsequently, in December 2012, the FDA announced the withdrawal of the 32 mg intravenous dose due to serious cardiac risks. Despite these safety concerns, the United States remains the primary destination for Indian ondansetron exports, accounting for 58.8% of the total export value. This underscores the importance of stringent compliance with FDA regulations for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, ondansetron is subject to marketing authorization by the European Medicines Agency (EMA) or national competent authorities. The EMA has conducted periodic safety update report single assessments (PSUSAs) for ondansetron, with the most recent assessment published in January 2022. (ema.europa.eu) This assessment led to variations in the product information to enhance safety measures. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to the EU and UK markets.

3WHO Essential Medicines & Global Standards

Ondansetron is included in the World Health Organization's Model List of Essential Medicines, reflecting its significance in global healthcare. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, ondansetron is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including ondansetron, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceuticals, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for ondansetron have expired, leading to a robust generic market with multiple manufacturers producing the drug. This has resulted in competitive pricing and widespread availability, benefiting both healthcare providers and patients globally.

6Recent Industry Developments

In October 2024, the FDA issued Import Alert 66-66, targeting active pharmaceutical ingredients (APIs) that appear to be misbranded under section 502(f)(1) due to labeling deficiencies. While this alert does not specifically mention ondansetron, it underscores the necessity for exporters to ensure compliance with labeling requirements to avoid potential import restrictions.

In January 2022, the EMA published the PSUSA for ondansetron, leading to updates in product information to enhance safety measures. (ema.europa.eu) This reflects the ongoing commitment to monitoring and improving the safety profile of ondansetron within the EU.

These developments highlight the dynamic nature of the regulatory environment for ondansetron and the importance of continuous compliance with international standards to maintain market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ondansetron

Retail & reference prices across 9 markets vs. India FOB export price of $1.72/unit

Global Price Benchmark for Ondansetron across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, multiple generic manufacturers are approved, contributing to competitive pricing.
United Kingdom	$0.40	GBP	The NHS Drug Tariff, as of March 2026, lists the reimbursement price for generic Ondansetron 8mg tablets at £0.30 each.
Germany	$0.38	EUR	The Federal Joint Committee (G-BA) sets the reimbursement prices for pharmaceuticals, with the current reference price for Ondansetron 8mg tablets at €0.35.
Australia

Supply Chain Risk Assessment — Ondansetron

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Ondansetron, heavily relies on imported Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), with a significant portion sourced from China. This dependency exposes the supply chain to risks associated with geopolitical tensions and trade disruptions. For instance, prior to 2020, India imported approximately 70% of its APIs from China, underscoring the vulnerability of its pharmaceutical sector to external supply shocks.

The COVID-19 pandemic highlighted these vulnerabilities, prompting the Indian government to implement the Production Linked Incentive (PLI) Scheme in 2020. This initiative aims to bolster domestic API and KSM manufacturing capabilities, thereby reducing reliance on imports. While the PLI scheme has led to increased investment in local production facilities, the transition to self-sufficiency is ongoing, and the industry remains susceptible to external supply chain disruptions in the interim. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five exporters of Ondansetron from India account for 60.9% of the total export value, with AUROBINDO PHARMA LTD alone contributing 25.8%. This high supplier concentration poses a significant risk; any operational or regulatory issues affecting these key exporters could disrupt the global supply of Ondansetron.

Access Complete Ondansetron Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 8,469 transactions across 157 markets.

Request Demo View Pricing

Frequently Asked Questions — Ondansetron Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ondansetron exporters from India?

The leading ondansetron exporters from India are AUROBINDO PHARMA LTD, GLENMARK PHARMACEUTICALS LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, and 12 others. AUROBINDO PHARMA LTD leads with 25.8% market share ($31.2M). The top 5 suppliers together control 60.9% of total export value.

What is the total export value of ondansetron from India?

The total export value of ondansetron from India is $121.0M, recorded across 8,469 shipments from 537 active exporters to 157 countries. The average shipment value is $14.3K.

Which countries import ondansetron from India?

India exports ondansetron to 157 countries. The top importing countries are UNITED STATES (58.8%), AUSTRALIA (6.0%), SOUTH AFRICA (5.7%), CANADA (3.1%), BELGIUM (2.3%), which together account for 76.0% of total export value.

What is the HS code for ondansetron exports from India?

The primary HS code for ondansetron exports from India is 30049035. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ondansetron

Ondansetron

Top Ondansetron Exporters from India

Top Countries Importing Ondansetron from India

Who Supplies Ondansetron to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Ondansetron — Export Intelligence Video

Regulatory Landscape — Ondansetron

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ondansetron

Supply Chain Risk Assessment — Ondansetron

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ondansetron Trade Intelligence

Frequently Asked Questions — Ondansetron Exports from India

Who are the top ondansetron exporters from India?

What is the total export value of ondansetron from India?

Which countries import ondansetron from India?

What is the HS code for ondansetron exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ondansetron exports from India?

Which ports handle ondansetron exports from India?

Why is India a leading exporter of ondansetron?

What certifications do Indian ondansetron exporters need?

How many buyers import ondansetron from India?

What is the market share of the top ondansetron exporter from India?

Analysis Methodology